(Circulation. 2004;110:2074-2076.)
© 2004 American Heart Association, Inc.
Editorial |
From the National Heart, Lung and Blood Institute, Bethesda, Md; the National Heart, Lung and Blood Institutes Framingham Heart Study, Framingham, Mass; and the Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston Mass.
Correspondence to Christopher J. ODonnell, MD, MPH, Framingham Heart Study, 73 Mount Wayte Ave, Suite #2, Framingham, MA 01702. E-mail codonnell@nih.gov
Key Words: Editorials genetics risk factors coronary disease prevention
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
With completion of the human genome sequence, expectations are rising that a detailed catalogue will soon be available of all important common genetic susceptibility variants for human diseases, including coronary heart disease (CHD) and related atherosclerotic cardiovascular disease (CVD).1 In light of this seminal event in medical research, it is curious that the family history of CHD has not been accorded a more central role in risk prediction and disease prevention by clinicians and public health professionals. A positive family history of CHD is present in the majority of cases of premature-onset CHD.2 In cases of familial hypercholesterolemia and other rare forms of premature-onset CVD, CHD clearly segregates in a mendelian fashion. For most cases of premature-onset CHD, the mode of genetic transmission in families is less clear. Although the family history of CHD has been considered a putative risk factor for decades, it has not been incorporated along with other established risk factors such as hyperlipidemia, hypertension, and cigarette smoking in some widely applied multivariable risk algorithms,3 though other risk algorithms do incorporate family history information.4
See p 2150
This cautious approach to widespread application of family history information is not due to insufficient evidence. Risks for CHD death are greatest in monozygotic (identical) compared with dizygotic (nonidentical) twins, particularly when there is a premature (eg, <65 years) age of onset in the initially affected twin.5 In multiple prospective studies involving hundreds of thousands of men and women, a parental history of premature CHD is a significant risk factor
Related Article:
Circulation 2004 110: 2150-2156.
This article has been cited by other articles:
![]() |
A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors In Vivo, September 1, 2009; 23(5): 797 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, and C. Stefanadis Hierarchical Analysis of Cardiovascular Risk Factors in Relation to the Development of Acute Coronary Syndromes, in Different Parts of Greece: The CARDIO2000 Study Angiology, May 1, 2008; 59(2): 156 - 165. [Abstract] [PDF] |
||||
![]() |
N. I. Parikh, S.-J. Hwang, M. G. Larson, L. A. Cupples, C. S. Fox, E. S. Manders, J. M. Murabito, J. M. Massaro, U. Hoffmann, and C. J. O'Donnell Parental Occurrence of Premature Cardiovascular Disease Predicts Increased Coronary Artery and Abdominal Aortic Calcification in the Framingham Offspring and Third Generation Cohorts Circulation, September 25, 2007; 116(13): 1473 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stern Symptoms Other Than Chest Pain May Be Important in the Diagnosis of "Silent Ischemia," or "The Sounds of Silence" Circulation, June 21, 2005; 111(24): e435 - e437. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |